Nestle ups stake in food allergy drug developer

Nestle ’s health science arm will pay $98 million to raise its stake in Aimmune Therapeutics, as the drug developer prepares to submit a marketing application for its peanut allergy treatment before the end of the year.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news